Nicole Gifford
FDA Grants Tentative Approval for Merck’s Insulin Glargine
Biosimilars Law Bulletin ·
FDA Advisory Committee Recommends Approval of CAR-T Cell Therapy and Two New Biosimilars
Biosimilars Law Bulletin ·
Boehringer Ingelheim Prevails in IPR Against AbbVie’s ’135 Humira Patent
Biosimilars Law Bulletin ·
Pfizer Challenges Another Herceptin® Patent With Two New IPR Petitions
Biosimilars Law Bulletin ·
Celltrion’s Application for Rituxan® (rituximab) Biosimilar Accepted by FDA
Biosimilars Law Bulletin ·